
Cybille Delacroix Muirhei
Examiner (ID: 18979)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1102, 1614, 1654, 1811 |
| Total Applications | 893 |
| Issued Applications | 513 |
| Pending Applications | 176 |
| Abandoned Applications | 204 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6128598
[patent_doc_number] => 20020076469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Composition and method'
[patent_app_type] => new
[patent_app_number] => 09/922632
[patent_app_country] => US
[patent_app_date] => 2001-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2353
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076469.pdf
[firstpage_image] =>[orig_patent_app_number] => 09922632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/922632 | Composition and method | Aug 5, 2001 | Abandoned |
Array
(
[id] => 1265094
[patent_doc_number] => 06660743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol'
[patent_app_type] => B1
[patent_app_number] => 09/890344
[patent_app_country] => US
[patent_app_date] => 2001-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3283
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890344
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890344 | Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol | Jul 25, 2001 | Issued |
| 09/857527 | Myt1 kinase inhibitors | Jul 25, 2001 | Abandoned |
Array
(
[id] => 6096964
[patent_doc_number] => 20020052377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Method for treating angina'
[patent_app_type] => new
[patent_app_number] => 09/910113
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9601
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052377.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910113
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910113 | Method for treating angina | Jul 19, 2001 | Abandoned |
Array
(
[id] => 6861674
[patent_doc_number] => 20030092682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Use of doxycycline for treatment of certain skin and mouth ailments'
[patent_app_type] => new
[patent_app_number] => 09/910317
[patent_app_country] => US
[patent_app_date] => 2001-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1282
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092682.pdf
[firstpage_image] =>[orig_patent_app_number] => 09910317
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/910317 | Use of doxycycline for treatment of certain skin and mouth ailments | Jul 19, 2001 | Abandoned |
Array
(
[id] => 7625437
[patent_doc_number] => 06723732
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Percutaneously adminstrable preparations containing cerebral function activators'
[patent_app_type] => B1
[patent_app_number] => 09/830113
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5486
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723732.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830113
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830113 | Percutaneously adminstrable preparations containing cerebral function activators | Jul 18, 2001 | Issued |
Array
(
[id] => 6736103
[patent_doc_number] => 20030013738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'LAMINITIS IN HORSES'
[patent_app_type] => new
[patent_app_number] => 09/906386
[patent_app_country] => US
[patent_app_date] => 2001-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2635
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013738.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906386
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906386 | Laminitis in horses | Jul 15, 2001 | Issued |
Array
(
[id] => 1228597
[patent_doc_number] => 06696440
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-24
[patent_title] => 'Treatment of asthma with MEK inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/889091
[patent_app_country] => US
[patent_app_date] => 2001-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20865
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696440.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889091
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889091 | Treatment of asthma with MEK inhibitors | Jul 10, 2001 | Issued |
Array
(
[id] => 6623965
[patent_doc_number] => 20020016307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity'
[patent_app_type] => new
[patent_app_number] => 09/901166
[patent_app_country] => US
[patent_app_date] => 2001-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4300
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016307.pdf
[firstpage_image] =>[orig_patent_app_number] => 09901166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/901166 | Pharmaceutical composition with both a lipase inhibitor and a lipophilic polysaccharide and an improved method for treating adiposity | Jul 8, 2001 | Abandoned |
Array
(
[id] => 5950830
[patent_doc_number] => 20020006431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Disposable absorbent article containing an essential oil'
[patent_app_type] => new
[patent_app_number] => 09/900319
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4192
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006431.pdf
[firstpage_image] =>[orig_patent_app_number] => 09900319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/900319 | Disposable absorbent article containing an essential oil | Jul 5, 2001 | Abandoned |
| 09/720361 | Compositions and methods for inducing cell death | Jul 4, 2001 | Abandoned |
Array
(
[id] => 1450757
[patent_doc_number] => 06455568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-09-24
[patent_title] => 'Combination therapy for inhibiting sphincter incontinence'
[patent_app_type] => B2
[patent_app_number] => 09/896227
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10153
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455568.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896227
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896227 | Combination therapy for inhibiting sphincter incontinence | Jun 28, 2001 | Issued |
Array
(
[id] => 6000636
[patent_doc_number] => 20020028805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Methods of inhibiting uterotrophic effects of estrogenic agents'
[patent_app_type] => new
[patent_app_number] => 09/896441
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8205
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028805.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896441
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896441 | Methods of inhibiting uterotrophic effects of estrogenic agents | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6477014
[patent_doc_number] => 20020022617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Methods for increasing nitric oxide synthase activity'
[patent_app_type] => new
[patent_app_number] => 09/896360
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9683
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022617.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896360
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896360 | Methods for increasing nitric oxide synthase activity | Jun 28, 2001 | Abandoned |
Array
(
[id] => 1399621
[patent_doc_number] => 06531508
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => 'Antibacterial medicinal compositions'
[patent_app_type] => B1
[patent_app_number] => 09/856094
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4612
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531508.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856094 | Antibacterial medicinal compositions | Jun 25, 2001 | Issued |
Array
(
[id] => 6476909
[patent_doc_number] => 20020022610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Compositions and methods for treating bacterial infections'
[patent_app_type] => new
[patent_app_number] => 09/886641
[patent_app_country] => US
[patent_app_date] => 2001-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6338
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022610.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886641
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886641 | Compositions and methods for treating bacterial infections | Jun 20, 2001 | Issued |
Array
(
[id] => 1414028
[patent_doc_number] => 06514537
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Magnesium citrate solution'
[patent_app_type] => B1
[patent_app_number] => 09/867017
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3010
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514537.pdf
[firstpage_image] =>[orig_patent_app_number] => 09867017
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/867017 | Magnesium citrate solution | May 28, 2001 | Issued |
Array
(
[id] => 1575252
[patent_doc_number] => 06469019
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-22
[patent_title] => 'Therapeutic application of nicergoline'
[patent_app_type] => B2
[patent_app_number] => 09/863623
[patent_app_country] => US
[patent_app_date] => 2001-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1840
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469019.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863623
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863623 | Therapeutic application of nicergoline | May 22, 2001 | Issued |
Array
(
[id] => 6477746
[patent_doc_number] => 20020022668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections'
[patent_app_type] => new
[patent_app_number] => 09/861841
[patent_app_country] => US
[patent_app_date] => 2001-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11112
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022668.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861841
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861841 | Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections | May 20, 2001 | Issued |
Array
(
[id] => 6625439
[patent_doc_number] => 20020016359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Compositions and methods of treating neurodegenerative diseases'
[patent_app_type] => new
[patent_app_number] => 09/862132
[patent_app_country] => US
[patent_app_date] => 2001-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2590
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016359.pdf
[firstpage_image] =>[orig_patent_app_number] => 09862132
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/862132 | Compositions and methods of treating neurodegenerative diseases | May 20, 2001 | Abandoned |